IRWD Ironwood Pharmaceuticals
- 6.530
- -0.110-1.66%
Ironwood Pharmaceuticals News
Ironwood Pharmaceuticals | 8-K: Ironwood Pharmaceuticals Reports First Quarter 2024 Results
Ironwood Pharmaceuticals | DEF 14A: Definitive information statements
Ironwood Pharmaceuticals | DEFA14A: Others
Ironwood Pharmaceuticals | 8-K: Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
Ironwood Pharmaceuticals | 8-K: Current report
Ironwood Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ironwood Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Ironwood Pharmaceuticals | 8-K: Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Ironwood Pharmaceuticals | 8-K/A: Current report (Amendment)
Ironwood Pharmaceuticals | 8-K: Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
Ironwood Pharmaceuticals | 8-K: Current report
Ironwood Pharmaceuticals | 8-K: Current report
Ironwood Pharmaceuticals | 8-K: Current report
Ironwood Pharmaceuticals | 8-K: Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance
Ironwood Pharmaceuticals | DEFA14A: Others
Ironwood Pharmaceuticals | DEF 14A: Definitive proxy statements
Ironwood Pharmaceuticals | 8-K: Current report
Ironwood Pharmaceuticals | 8-K: Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results
Ironwood Pharmaceuticals | 8-K: Current report
Ironwood Pharmaceuticals | 8-K: Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
Analysis
Price Target
No Data
